No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs540431033 |
chr2:37383076-37383077 |
Weak transcription Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs74698719 |
chr2:37383093-37383094 |
Weak transcription Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs70949736 |
chr2:37383097-37383098 |
Weak transcription Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs201980021 |
chr2:37383098-37383099 |
Weak transcription Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs532662016 |
chr2:37383138-37383139 |
Weak transcription Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs550888143 |
chr2:37383153-37383154 |
Weak transcription Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs4670666 |
chr2:37383166-37383167 |
Weak transcription Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
7 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs530009859 |
chr2:37383239-37383240 |
Active TSS Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs12712526 |
chr2:37383315-37383316 |
Active TSS Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
7 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
10 |
rs78914684 |
chr2:37383390-37383391 |
Active TSS Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs192326827 |
chr2:37383448-37383449 |
Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs546807423 |
chr2:37383479-37383480 |
Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs571514611 |
chr2:37383522-37383523 |
Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs184662377 |
chr2:37383542-37383543 |
Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs13008681 |
chr2:37383625-37383626 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
16 |
rs115509351 |
chr2:37383682-37383683 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs535824504 |
chr2:37383706-37383707 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs149073456 |
chr2:37383727-37383728 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs142876454 |
chr2:37383771-37383772 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS
|
Chromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs11899117 |
chr2:37383772-37383773 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS
|
Chromatin interactive region
|
5 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
21 |
rs565113590 |
chr2:37383790-37383791 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS
|
Chromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs11904602 |
chr2:37383830-37383831 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
5 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
23 |
rs544415496 |
chr2:37383868-37383869 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs572686720 |
chr2:37383898-37383899 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs562816675 |
chr2:37383900-37383901 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs530428103 |
chr2:37384001-37384002 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs539954844 |
chr2:37384007-37384008 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs541820062 |
chr2:37384040-37384041 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs564207041 |
chr2:37384053-37384054 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs376636931 |
chr2:37384054-37384055 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs560574348 |
chr2:37384061-37384062 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs57835937 |
chr2:37384085-37384086 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs112719085 |
chr2:37384108-37384109 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs552733788 |
chr2:37384117-37384118 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs571453196 |
chr2:37384179-37384180 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs532317149 |
chr2:37384193-37384194 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs550796996 |
chr2:37384194-37384195 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs569013845 |
chr2:37384199-37384200 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs536586330 |
chr2:37384213-37384214 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs111463611 |
chr2:37384240-37384241 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs189126736 |
chr2:37384245-37384246 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs573303340 |
chr2:37384248-37384249 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs544154430 |
chr2:37384254-37384255 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs12992188 |
chr2:37384283-37384284 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs62133148 |
chr2:37384296-37384297 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs13018861 |
chr2:37384328-37384329 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs12992818 |
chr2:37384362-37384363 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
8 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
48 |
rs12992610 |
chr2:37384383-37384384 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
49 |
rs113554883 |
chr2:37384430-37384431 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs7340267 |
chr2:37384460-37384461 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
8 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|